Sema4 Holdings Corp. (SMFR)


+0.07 (+26.78%)
Symbol SMFR
Price $0.3106
Beta 0.000
Volume Avg. 2.01M
Market Cap 246.373M
Shares () -
52 Week Range 0.22-4.09
1y Target Est -
DCF Unlevered SMFR DCF ->
DCF Levered SMFR LDCF ->
ROE -130.96% Strong Sell
ROA -106.92% Strong Sell
Operating Margin -
Debt / Equity 22.93% Neutral
P/E -
P/B 18.97 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest SMFR news

Mr. Jason Ryan
Health Information Services
NASDAQ Global Select

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.